Back to top

GE Helps MB Real Estate to Buy MOB

Read MoreHide Full Article

GE Capital, Healthcare Financial Services, an operating unit of General Electric Company (GE - Free Report) , recently provided a debt financing of $89 million to full-service commercial real estate firm MB Real Estate to fund the acquisition of a medical office building (MOB) in Atlanta, Ga.

Headquartered in Chicago, MB Real Estate offers a diversified portfolio of asset and facilities management services, leasing, project and construction management, tenant representation and investment services to private and public organizations across the country.

MB Real Estate has added a prized asset in its kitty as this MOB was recognized in 2012 as the Best International Medical Office Building of the Year by Building Owners and Managers Association International (BOMA). The eight-storied building serves as the headquarters for Piedmont Healthcare, one of the largest physician-owned and directed, multi-specialty groups in North Carolina and the Southeast region.   

General Electric is one of the largest and the most diversified technology and financial services corporations in the world. With products and services ranging from aircraft engines, power generation, water processing, and security technology to medical imaging, business and consumer financing, media content, and industrial products, the company serves over 100 million customers worldwide.

Its segments include Power & Water, Oil & Gas, Energy Management, Aviation, Healthcare, Transportation, Home & Business Solutions, and GE Capital. With more than 60 senior secured MOB financings since 2011, GE Capital, Healthcare Financial Services has an in-depth industry know-how and expertise as a reliable debt provider.

General Electric currently has a Zacks Rank #3 (Hold). Other companies in the industry that are worth mentioning include Compass Diversified Holdings (CODI - Free Report) , ITT Corporation (ITT - Free Report) and Honeywell International Inc. (HON - Free Report) , each carrying a Zacks Rank #2 (Buy).

More from Zacks Analyst Blog

You May Like